Liquid chromatography/electrospray ionization tandem mass spectroscopy (LC/ESI MS/MS) analysis of 1,2-epoxybutene adducts of purine deoxynucleosides.

[1]  L. Marnett,et al.  Characterization of endogenous DNA adducts by liquid chromatography/electrospray ionization tandem mass spectrometry , 1995 .

[2]  I. Blair.  Mass Spectrometry in Drug Disposition and Pharmacokinetics , 1994 .

[3]  R. Melnick,et al.  Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control. , 1993, Carcinogenesis.

[4]  J. A. Ruth,et al.  A simplified methodology for quantitation of butadiene metabolites. Application to the study of 1,3-butadiene metabolism by rat liver microsomes. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[5]  L. Marnett,et al.  A thermospray liquid chromatography/mass spectrometry method for analysis of human urine for the major malondialdehyde-guanine adduct. , 1992, Chemical research in toxicology.

[6]  A. Elfarra,et al.  1,3-Butadiene oxidation by human myeloperoxidase. Role of chloride ion in catalysis of divergent pathways. , 1992, The Journal of biological chemistry.

[7]  J. A. Bond,et al.  Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. , 1992, Carcinogenesis.

[8]  R. Laib,et al.  Species differences in DNA damage by butadiene: role of diepoxybutane. , 1989, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[9]  J. A. Bond,et al.  Species differences in the disposition of inhaled butadiene. , 1986, Toxicology and applied pharmacology.

[10]  G. Bellucci,et al.  The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts. , 1984, Carcinogenesis.